Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity.
Eastman RT, Rusinova R, Herold KF, Huang XP, Dranchak P, Voss TC, Rana S, Shrimp JH, White AD, Hemmings HC Jr, Roth BL, Inglese J, Andersen OS, Dahlin JL.
Eastman RT, et al. Among authors: hemmings hc jr.
bioRxiv [Preprint]. 2023 Oct 24:2023.10.23.563088. doi: 10.1101/2023.10.23.563088.
bioRxiv. 2023.
PMID: 37961094
Free PMC article.
Preprint.